• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,635.25
    -250.60 (--0.43%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 295.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 20,400.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novelix Pharmaceuticals Ltd Trading

  • Indian Private
  • BSE Code : 33252.0
  • ISIN : INE314I01036
73.97 1 (1.34%)
  • As on 14 Aug 2026 (EOD)

  • Today’s Low

    72.99

  • Today’s High

    73.99

  • Open

    72.99

  • Perv Close

    72.99

  • 52W Low

    38.00

  • 52W High

    92.00

Key Indicators

  • P/E(TTM)

    82.19

  • Mar.Cap (₹Cr.)

    210.59

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.08

  • Debt-Equity Ratio

    1.34

  • AGM Date

    13-Aug-2026

  • EPS

    0.90

  • P/E Ratio

    82.19

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    210.59

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.47

  • BV (₹)

    23.10

  • Sales( ₹ in Cr.)

    132.31

  • NP (in Cr.)

    2.56

  • NP Var(%)

    2925.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    210.59

  • 52 Week High

    92.00

  • 52 Week Low

    38.00

  • Price BSE

    74.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    210.59

  • P/C Ratio

    79.30

  • P/E Ratio

    82.40

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 30.72 4.22 1.92 1.14 1.31 1.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.72 4.22 1.92 1.14 1.31 1.50
Other Income 0.02 0.31 0.00 0.25 0.00 0.00
Stock Adjustments -0.35 0.37 0.29 0.28 -0.14 -0.02
Total Income 30.39 4.90 2.21 1.67 1.17 1.48
EXPENDITURE :            
Raw Materials 29.22 4.21 1.64 1.09 0.88 0.73
Power and Fuel Cost 0.00 0.01 0.01 0.01 0.01 0.02
Employee Cost 0.07 0.13 0.16 0.14 0.15 0.13
Other Manufacturing Expenses 0.01 0.01 0.02 0.02 0.03 0.05
Selling and Administration Expenses 0.91 0.35 0.36 0.38 0.31 0.35
Miscellaneous Expenses 0.01 0.14 0.01 1.53 2.98 0.01
Employee Benefit Expenses 0.07 0.13 0.16 0.14 0.15 0.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 30.22 4.84 2.21 3.17 4.36 1.29
Operating Profit 0.16 0.06 0.00 -1.49 -3.19 0.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.16 0.06 0.00 -1.49 -3.19 0.18
Depreciation 0.04 0.04 0.06 0.07 0.08 0.08
Profit Before Tax 0.12 0.02 -0.06 -1.56 -3.27 0.10
Current Tax 0.03 0.00 0.00 0.00 0.00 0.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.01 0.00 -0.01 0.00 0.01
Reported Net Profit 0.08 0.01 -0.06 -1.56 -3.27 0.09
Extraordinary Items 0.00 0.00 0.00 -0.02 0.00 0.00
Adjusted Net Profit 0.08 0.01 -0.06 -1.54 -3.27 0.09
Adjustment below Net Profit 0.00 -0.01 0.01 0.00 0.00 -0.03
P & L Balance brought forward -1.96 -1.96 -2.37 -0.81 2.53 2.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.01 0.00 0.07 0.03
P & L Balance carried down -1.88 -1.96 -2.43 -2.37 -0.81 2.53
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.08 0.01 -0.07 -1.93 -4.04 0.12
Earnings Per Share(Adj)-Unit Curr 0.08 0.01 -0.07 -1.93 -4.04 0.12
Book Value 17.63 9.08 8.88 8.94 10.87 14.90
Book Value(Adj)-Unit Curr 17.63 9.08 8.88 8.94 10.87 14.90

Shareholding Pattern

  • Promoter Group

    54.29%

  • Public Share Holding

    45.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,002,000 35.13 10,002,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,455,733 19.16 5,455,733 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,457,733 54.29 15,457,733 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 670,151 2.35 662,051 21
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 234,711 0.82 234,711 11
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 44,724 0.16 44,724 42
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,452,533 36.71 10,419,133 84
Individuals holding nominal share capital up to Rs. 1 lakh 1,469,701 5.16 1,187,391 2,958
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 125,900 0.44 125,900 1
Sub Total 13,012,267 45.71 12,688,457 3,119
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,470,000 100.00 28,146,190 3,127

Company Background

Novelix Pharmaceuticals LtdTrading

  • Novelix Pharmaceuticals Ltd
  • BSE Code : 33252.0
  • ISIN : INE314I01036

  • Incorporation Year

    1994

  • Registered Office

    4-4-231/1/2/ABC Inderbagh
    Sultan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-24757370

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Nishita Kalantri

  • Auditor

    CVS Bala Chandra Rao & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Novelix Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novelix Pharma. 73.97 30.73 30.72 82.19 0.84
Abbott India 27,617.45 7,217.19 6,929.05 37.81 43.78
Astrazeneca Phar 7,791.60 2,304.07 2,275.58 114.84 27.86
P & G Health Ltd 5,922.40 944.52 934.17 27.55 71.75
Glaxosmi. Pharma 2,664.65 3,932.76 3,790.20 42.57 58.17
Cipla 1,461.00 20,102.60 18,979.95 38.40 13.88
Bliss GVS Pharma 512.60 773.53 729.81 56.21 12.51
Amrutanjan Healt 491.85 469.50 451.82 26.34 21.89
Fermenta Biotec. 459.55 474.15 450.25 21.45 18.77
Guj. Themis Bio. 347.45 152.47 150.80 77.73 27.21
Ambalal Sarabhai 41.28 19.52 3.94 28.87 6.77